Blood based cancers. Since my own husband died of multiple myeloma, this is a bittersweet show for me. However, I really want to focus on leukemia and myeloma, what they are, their symptoms, risk factors, etc. My guest is Dr. Daniel Pollyea, an investigator at the University of Colorado Cancer Center, clinical director of leukemia services at University of Colorado Hospital, and assistant professor of oncology at the University of Colorado School of Medicine.
The chemo drug shortage. How many are dying for their drugs? In 2008, only 3 cancer drugs were on backorder. In 2011, 23 cancer drugs were in short supply from supplier to patient. The reasons are multiple and complex. And what of the patients? Brenda was told there was no more Doxil available. She’s mad, frustrated, angry and dying for a solution to the drug shortage. My guest is Ted Okon, executive director, Community Oncology Alliance (COA), who testified before the house and Senate on this subject. He will be joined by Dr. Richard Frame, who is the medical advisor for the Community Oncology Alliance Patient Advocacy Network (CPAN).